AKT1 and neoplasm: In the ovarian cancer cell lines A2780 and SKOV3, TMP in combination with paclitaxel suppressed angiogenesis by inhibiting the ERK1/2 and Akt pathways and promoted the apoptosis of tumor cells to enhance the antitumor effects of paclitaxel compared with treatment alone.